The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 16, 2019

Filed:

Jun. 06, 2016
Applicants:

University of Georgia Research Foundation, Inc., Athens, GA (US);

The United States of America, As Represented BY the Secretary of the Army, Washington, DC (US);

Inventors:

Scott Pegan, Athens, GA (US);

Steven P. Harvey, Lutherville, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/16 (2006.01); A61K 31/55 (2006.01); A61L 2/16 (2006.01); A61K 31/44 (2006.01); A61K 31/46 (2006.01); A61K 38/00 (2006.01); A61K 31/5513 (2006.01); A61K 31/4425 (2006.01);
U.S. Cl.
CPC ...
C12N 9/16 (2013.01); A61K 31/4425 (2013.01); A61K 31/46 (2013.01); A61K 31/5513 (2013.01); A61L 2/16 (2013.01); C12Y 301/08002 (2013.01); A61K 38/00 (2013.01);
Abstract

Genetically engineered organophosphorus acid anhydrolases (OPAA) with improved catalytic efficiency and relaxed stereospecificity are provided. The variants typically include a mutation at the residue corresponding to H343 of wildtypesp. OPAA. The mutation allows the OPAA enzyme to effectively process both VR enantiomers. The OPAA optionally include one or more mutations selected the residues corresponding to Y212, V342, and I215 of wildtypesp. OPAA which improve the enzyme's catalytic efficiency for VX and VR. A particularly preferred OPAA includes mutations at the residues corresponding Y212F, V342L, I215Y, and H343D relative to wildtypesp. OPAA. Compositions including an effective amount of OPAA to increase hydrolysis of an organophosphate, and methods of use thereof for treating subjects exposed to an organophosphate, or a surface or liquid contaminated with an organophosphate are also provided.


Find Patent Forward Citations

Loading…